5-HT4 receptors located on cholinergic nerves in human colon circular muscle

被引:50
作者
Leclere, PG
Prins, NH
Schuurkes, JAJ
Lefebvre, RA
机构
[1] State Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium
[2] Johnson & Johnson Pharmaceut Res & Dev, Dept Gastrointestinal Pharmacol, Beerse, Belgium
关键词
acetylcholine; cholinergic nerves; 5-hydroxytryptamine; 4; receptor; human colon;
D O I
10.1111/j.1365-2982.2005.00621.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
5-Hydroxytryptamine 4 (5-HT4) receptor agonists promote colonic propulsion. The alteration of circular muscle (CM) motility underlying this involves inhibition of contractility via smooth muscle 5-HT4 receptors and proximal colonic motility stimulation, the mechanism of the latter not having been characterized. Our aim was to identify and characterize a 5-HT4 receptor-mediated stimulation of human colon CM contractile activity. 5-HT4 receptor ligands were tested on electrical field stimulation (EFS)-induced contractions of human colonic muscle strips cut in the circular direction (called 'whole tissue' strips). Additionally, after incubation of tissues with [H-3]-choline these compounds were tested on EFS-induced release of tritium in whole tissue strips and in 'isolated' CM strips, obtained by superficial cutting in the CM layer. Tetrodotoxin and atropine blocked EFS-induced contractions of whole tissue CM strips. Prucalopride (0.3 mu mol L-1) evoked a heterogenous response on EFS-induced contraction, ranging from inhibition (most frequently observed) to enhancement. In the release experiments, EFS-induced tritium efflux was blocked by tetrodotoxin. Prucalopride increased EFS-induced tritium and [H-3]-acetylcholine efflux in whole tissue and in isolated CM strips. All effects of prucalopride were antagonized by the selective 5-HT4 receptor antagonist GR113808. The results obtained indicate the presence of excitatory 5-HT4 receptors on cholinergic nerves within the CM of human colon.
引用
收藏
页码:366 / 375
页数:10
相关论文
共 24 条
[1]   INVOLVEMENT OF NITRIC-OXIDE IN THE INHIBITORY INNERVATION OF THE HUMAN ISOLATED COLON [J].
BOECKXSTAENS, GE ;
PELCKMANS, PA ;
HERMAN, AG ;
VANMAERCKE, YM .
GASTROENTEROLOGY, 1993, 104 (03) :690-697
[2]   Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans [J].
Bouras, EP ;
Camilleri, M ;
Burton, DD ;
McKinzie, S .
GUT, 1999, 44 (05) :682-686
[3]   Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs [J].
Briejer, MR ;
Prins, NH ;
Schuurkes, JAJ .
NEUROGASTROENTEROLOGY AND MOTILITY, 2001, 13 (05) :465-472
[4]   The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound [J].
Briejer, MR ;
Bosmans, JP ;
Van Daele, P ;
Jurzak, M ;
Heylen, L ;
Leysen, JE ;
Prins, NH ;
Schuurkes, JAJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 423 (01) :71-83
[5]   5-HT3 and 5-HT4 receptors and cholinergic and tachykininergic neurotransmission in the guinea-pig proximal colon [J].
Briejer, MR ;
Schuurkes, JAJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 308 (02) :173-180
[6]  
BURLEIGH DE, 1985, BRIT J CLIN PHARMACO, V20, P475
[7]   The effects of the specific 5HT4 receptor agonist, prucalopride, on colonic motility in healthy volunteers [J].
De Schryver, AMP ;
Andriesse, GI ;
Samsom, M ;
Smout, AJPM ;
Gooszen, HG ;
Akkermans, LMA .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (03) :603-612
[8]   Prucalopride, a systemic enterokinetic, for the treatment of constipation [J].
Emmanuel, AV ;
Roy, AJ ;
Nicholls, TJ ;
Kamm, MA .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (07) :1347-1356
[9]   Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers [J].
Emmanuel, AV ;
Kamm, MA ;
Roy, AJ ;
Antonelli, K .
GUT, 1998, 42 (04) :511-516
[10]   GR113808 - A NOVEL, SELECTIVE ANTAGONIST WITH HIGH-AFFINITY AT THE 5-HT4 RECEPTOR [J].
GALE, JD ;
GROSSMAN, CJ ;
WHITEHEAD, JWF ;
OXFORD, AW ;
BUNCE, KT ;
HUMPHREY, PPA .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (01) :332-338